238 related articles for article (PubMed ID: 17228187)
1. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
Modarresifar H; Almodovar S; Bass WB; Ojha B
Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
[TBL] [Abstract][Full Text] [Related]
2. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
Pahlka RB; Sonnad JR
Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
[TBL] [Abstract][Full Text] [Related]
3. Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications.
Courbon F; Caselles O; Zerdoud S; Duthil P; Regis H; Berry I; Caron P
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):363-70. PubMed ID: 17043635
[TBL] [Abstract][Full Text] [Related]
4. Radioactive 131I use in end-stage renal disease: nightmare or nuisance?
Sinsakul M; Ali A
Semin Dial; 2004; 17(1):53-6. PubMed ID: 14717812
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis.
Daumerie C; Vynckier S; Caussin J; Jadoul M; Squifflet JP; de Patoul N; Wambersie A
Thyroid; 1996 Aug; 6(4):301-4. PubMed ID: 8875750
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing dialysis for chronic renal failure: a dosimetric method.
Jiménez RG; Moreno AS; Gonzalez EN; Simón FJL ; Rodriguez JR; Jimenez JC; Córdoba MH; Albertino RV; Jimenez RA
Thyroid; 2001 Nov; 11(11):1031-4. PubMed ID: 11762712
[TBL] [Abstract][Full Text] [Related]
7. [Hemodialysis procedure in a patient treated with radioactive iodine].
Brunet P; Bourrelly M; Mundler O; Bouvier C; Faure V; Opris A; Bouchouareb D; Indreies M; Ramananarivo P; Dussol B; Berland Y
Nephrol Ther; 2008 Jun; 4(3):196-201. PubMed ID: 18272443
[TBL] [Abstract][Full Text] [Related]
8. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
[TBL] [Abstract][Full Text] [Related]
9. Radiation safety implications of 131I treatment in a patient with Grave's disease undergoing home hemodialysis.
Simpson JB; Godwin GA
Health Phys; 2006 Dec; 91(6):570-3. PubMed ID: 17099400
[TBL] [Abstract][Full Text] [Related]
10. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
[TBL] [Abstract][Full Text] [Related]
11. [Necessity to administer 131I in a patient with papillary thyroid carcinoma undergoing chronic hemodialysis].
Novik V; González R; Díaz M; Vega J
Rev Med Chil; 1998 Jul; 126(7):874-5. PubMed ID: 9830782
[No Abstract] [Full Text] [Related]
12. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
13. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
Murcutt G; Edwards J; Boakye J; Davenport A
Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
[TBL] [Abstract][Full Text] [Related]
14. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
16. A pragmatic protocol for I-131 rhTSH-stimulated ablation therapy in patients with renal failure.
Driedger AA; Quirk S; McDonald TJ; Ledger S; Gray D; Wall W; Yoo J
Clin Nucl Med; 2006 Aug; 31(8):454-7. PubMed ID: 16855429
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
Coover LR; Silberstein EB; Kuhn PJ; Graves MW
J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
[TBL] [Abstract][Full Text] [Related]
18. Radiation protection procedures in 131I treatments for thyroid cancer in patients requiring hemodialysis.
Fioroni F; Sghedoni R; Grassi E; Piccagli V; Sollini M; Filice A; Versari A; Iori M
Nucl Med Commun; 2014 Jun; 35(6):626-30. PubMed ID: 24584218
[TBL] [Abstract][Full Text] [Related]
19. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
Parthasarathy KL; Crawford ES
J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
[TBL] [Abstract][Full Text] [Related]
20. Glycophorin A as a biological dosimeter for radiation dose to the bone marrow from iodine-131.
Jensen RH; Reynolds JC; Robbins J; Bigbee WL; Grant SG; Langlois RG; Pineda JD; Lee T; Barker WC
Radiat Res; 1997 Jun; 147(6):747-52. PubMed ID: 9189175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]